Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFNS Efficacy and Safety in Chinese Pediatric Allergic Rhinitis
NCT02424539Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2015
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone in allergic rhinitis (AR), sponsored by GSK. Started Sep 2015; status: completed.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02424539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424539.